Intravesical gemcitabine for non-muscle invasive bladder cancer [Intravesikales Gemcitabin für nicht-muskelinvasive Harnblasenkarzinome]

被引：0
|
作者：
Krabbe L.-M. [1 ]
Schmidt S. [2 ]
机构：
[1] Klinik für Urologie, Universitätsklinikum Münster, Albert-Schweitzer Campus 1, GB A1, Münster
[2] UroEvidence@Deutsche Gesellschaft für Urologie, Kuno-Fischer-Straße 8, Berlin
来源：
Der Urologe | 2015年 / 54卷 / 3期
关键词：
D O I：
10.1007/s00120-015-3779-2
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：402 / 405
页数：3
相关论文
共 50 条
  • [41] Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer
    Messing, Edward
    BLADDER CANCER, 2020, 6 (01) : 97 - 98
  • [42] Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naive patients with non-muscle invasive bladder cancer.
    Thomas, Lewis
    Steinberg, Ryan
    Nepple, Kenneth Gerard
    O'Donnell, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [43] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR BCG-NAIVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    McElree, Ian M.
    Steinberg, Ryan L.
    Martin, Alexander C.
    Richards, Jordan
    Mott, Sarah L.
    Gellhaus, Paul T.
    Nepple, Kenneth G.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E488 - E488
  • [44] Is single-dose postoperative intravesical gemcitabine effective to prevent recurrence in patients with non-muscle invasive bladder cancer?
    Jain, Abhishek
    Goel, Apul
    Sankhwar, S. N.
    INDIAN JOURNAL OF UROLOGY, 2010, 26 (01) : 153 - 155
  • [45] Real-word efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer
    Abou Chakra, Mohamad
    Packiam, Vignesh T.
    O'Donnell, Michael A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2081 - 2091
  • [46] Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer
    Lightfoot, Andrew J.
    Breyer, Benjamin N.
    Rosevear, Henry M.
    Erickson, Bradley A.
    Konety, Badrinath R.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 35.e15 - 35.e19
  • [47] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Escano, Manuel R. De Jesus
    Vertosick, Emily
    Benfante, Nicole
    Lenis, Andrew T.
    Reisz, Peter A.
    Goh, Alvin
    Cha, Eugene
    Donahue, Timothy F.
    Bochner, Bernard H.
    Sjoberg, Dan
    Pietzak, Eugene J.
    JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
  • [48] Intravesical Electromotive Drug Administration (R) (EMDA) with Mitomycin-C for non-muscle invasive bladder cancer
    Di Stasi, S. M.
    Dutto, L.
    Verri, C.
    UROLOGIA JOURNAL, 2008, 75 (04) : 214 - 220
  • [49] Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer
    Bakula, Mirko
    Hudolin, Tvrtko
    Knezevic, Nikola
    Zimak, Zoran
    Andelic, Jerko
    Juric, Ilija
    Gamulin, Marija
    Gnjidic, Milena
    Kastelan, Zeljko
    LIFE-BASEL, 2024, 14 (07):
  • [50] Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
    de Jong, Joep J.
    Hendricksen, Kees
    Rosier, Marloes
    Mostafid, Hugh
    Boormans, Joost L.
    BLADDER CANCER, 2018, 4 (04) : 395 - 401
12345